Plasma atrial natriuretic peptide

concentrations and circulating forms in normal man and patients with chronic renal failure

Kazuya Ogawa, A. Ian Smith, G. Peter Hodsman, Bruce Jackson, Elizabeth A. Woodcock, Colin I. Johnston

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)

Abstract

SUMMARY 1. A specific and sensitive radioimmunoassay has been developed and used to measure circulating atrial natriuretic peptide (ANP) in normal man and in patients with chronic renal failure. 2. Circulating ANP levels rose with head‐down tilt and exercise, and were raised in patients with chronic renal failure in proportion to volume status. This suggests that ANP release is mediated via increased atrial stretch, although other release mechanisms cannot be excluded. 3. Extracts of normal human plasma subjected to reverse phase HPLC showed one major peak of immunoreactivity co‐migrating with α‐human ANP. However, when plasma extracts from patients with renal failure were chromatographed on a similar system, a second later eluting peak of ANP immunoreactivity was observed. This may represent circulating ANP precursors or degradation molecules. 4. Significant arteriovenous differences in plasma ANP concentration were observed in patients with chronic renal failure. Arterial and venous plasma ANP levels decreased slightly after haemodialysis. Plasma ANP concentrations were inversely correlated with haematocrit in these patients.

Original languageEnglish
Pages (from-to)95-102
Number of pages8
JournalClinical and Experimental Pharmacology and Physiology
Volume14
Issue number2
DOIs
Publication statusPublished - 1 Jan 1987

Keywords

  • atrial natriuretic peptide
  • blood volume
  • exercise
  • radioimmunoassay
  • renal failure
  • reverse phase HPLC
  • right atrial pressure.

Cite this

@article{0a92aceb8a3e4ad6915dfc8372fb42d8,
title = "Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure",
abstract = "SUMMARY 1. A specific and sensitive radioimmunoassay has been developed and used to measure circulating atrial natriuretic peptide (ANP) in normal man and in patients with chronic renal failure. 2. Circulating ANP levels rose with head‐down tilt and exercise, and were raised in patients with chronic renal failure in proportion to volume status. This suggests that ANP release is mediated via increased atrial stretch, although other release mechanisms cannot be excluded. 3. Extracts of normal human plasma subjected to reverse phase HPLC showed one major peak of immunoreactivity co‐migrating with α‐human ANP. However, when plasma extracts from patients with renal failure were chromatographed on a similar system, a second later eluting peak of ANP immunoreactivity was observed. This may represent circulating ANP precursors or degradation molecules. 4. Significant arteriovenous differences in plasma ANP concentration were observed in patients with chronic renal failure. Arterial and venous plasma ANP levels decreased slightly after haemodialysis. Plasma ANP concentrations were inversely correlated with haematocrit in these patients.",
keywords = "atrial natriuretic peptide, blood volume, exercise, radioimmunoassay, renal failure, reverse phase HPLC, right atrial pressure.",
author = "Kazuya Ogawa and Smith, {A. Ian} and Hodsman, {G. Peter} and Bruce Jackson and Woodcock, {Elizabeth A.} and Johnston, {Colin I.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1111/j.1440-1681.1987.tb00962.x",
language = "English",
volume = "14",
pages = "95--102",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "2",

}

Plasma atrial natriuretic peptide : concentrations and circulating forms in normal man and patients with chronic renal failure. / Ogawa, Kazuya; Smith, A. Ian; Hodsman, G. Peter; Jackson, Bruce; Woodcock, Elizabeth A.; Johnston, Colin I.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 14, No. 2, 01.01.1987, p. 95-102.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Plasma atrial natriuretic peptide

T2 - concentrations and circulating forms in normal man and patients with chronic renal failure

AU - Ogawa, Kazuya

AU - Smith, A. Ian

AU - Hodsman, G. Peter

AU - Jackson, Bruce

AU - Woodcock, Elizabeth A.

AU - Johnston, Colin I.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - SUMMARY 1. A specific and sensitive radioimmunoassay has been developed and used to measure circulating atrial natriuretic peptide (ANP) in normal man and in patients with chronic renal failure. 2. Circulating ANP levels rose with head‐down tilt and exercise, and were raised in patients with chronic renal failure in proportion to volume status. This suggests that ANP release is mediated via increased atrial stretch, although other release mechanisms cannot be excluded. 3. Extracts of normal human plasma subjected to reverse phase HPLC showed one major peak of immunoreactivity co‐migrating with α‐human ANP. However, when plasma extracts from patients with renal failure were chromatographed on a similar system, a second later eluting peak of ANP immunoreactivity was observed. This may represent circulating ANP precursors or degradation molecules. 4. Significant arteriovenous differences in plasma ANP concentration were observed in patients with chronic renal failure. Arterial and venous plasma ANP levels decreased slightly after haemodialysis. Plasma ANP concentrations were inversely correlated with haematocrit in these patients.

AB - SUMMARY 1. A specific and sensitive radioimmunoassay has been developed and used to measure circulating atrial natriuretic peptide (ANP) in normal man and in patients with chronic renal failure. 2. Circulating ANP levels rose with head‐down tilt and exercise, and were raised in patients with chronic renal failure in proportion to volume status. This suggests that ANP release is mediated via increased atrial stretch, although other release mechanisms cannot be excluded. 3. Extracts of normal human plasma subjected to reverse phase HPLC showed one major peak of immunoreactivity co‐migrating with α‐human ANP. However, when plasma extracts from patients with renal failure were chromatographed on a similar system, a second later eluting peak of ANP immunoreactivity was observed. This may represent circulating ANP precursors or degradation molecules. 4. Significant arteriovenous differences in plasma ANP concentration were observed in patients with chronic renal failure. Arterial and venous plasma ANP levels decreased slightly after haemodialysis. Plasma ANP concentrations were inversely correlated with haematocrit in these patients.

KW - atrial natriuretic peptide

KW - blood volume

KW - exercise

KW - radioimmunoassay

KW - renal failure

KW - reverse phase HPLC

KW - right atrial pressure.

UR - http://www.scopus.com/inward/record.url?scp=0023262882&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1681.1987.tb00962.x

DO - 10.1111/j.1440-1681.1987.tb00962.x

M3 - Article

VL - 14

SP - 95

EP - 102

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 2

ER -